Syngene appoints Maninder Kapoor Puri as CHRO and Abhijit Zutshi as CCO
Both join the leading CRDMO’s executive committee to drive global people strategy and commercial expansion
Both join the leading CRDMO’s executive committee to drive global people strategy and commercial expansion
Dilip Shanghvi to continue as the Executive Chairman of the Board
Richard A. Gonzalez to retire from the board of directors effective July 1, 2025
Roger Dansey to become Interim Chief Oncology Officer and Johanna Bendell to join Pfizer as Oncology Chief Development Officer
Austin assumes role from Glenn F. Tilton, who will continue to serve as an independent director
Christoph Funke's extensive career includes leadership roles at organizations such as Fresenius Kabi and Strides Pharma Science
He is a former Neurology faculty member at The Johns Hopkins Hospital and an elected Fellow of the Royal College of Physicians, United Kingdom
Subscribe To Our Newsletter & Stay Updated